Social Media Ideas for Best In Biotech

Best Workplaces for Innovators 2026: Biotech, healthcare, and life sciences category winners

Of the 10 companies earning top honors from Fast Company judges in the biotech, healthcare, and life sciences fields category of Best Workplaces for Innovators 2026, half are in th...

Top SMid Biotechnology Stocks: JPMorgan’s Latest Pick

This week in charts: Biotech’s rebound is undeniable

Not only is the XBI continuing to hover around a historic high, but drug companies can’t seem to get enough of both large IPOs and big-ticket M&A.

<![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe...

Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?

One offers a more affordable entry point while the other boasts some of the highest profit margins in the sector. The choice comes down to whether you prioritize income stability o...

Pushing biotech forward in France: 10 companies to know about 

France is at the forefront of innovative biotech and Paris has become a vibrant startup ecosystem. Here are 10 top French biotech companies. The post Pushing biotech forward in Fra...

Navigating German biotech: 10 companies to keep an eye on in 2026 

The German biotech ecosystem is well established despite the challenges it is facing. Discover ten key Germany-based biotech companies. The post Navigating German biotech: 10 compa...

The biggest biotech funding rounds in August 2026

The companies Moderna, Amylyx Pharmaceuticals, and Braveheart Bio bagged the biggest biotech funding rounds overall in August 2026. The post The biggest biotech funding rounds in A...

The biggest biotech funding rounds in September 2026

The companies Moderna, Amylyx Pharmaceuticals, and Braveheart Bio bagged the biggest biotech funding rounds overall in August 2026. The post The biggest biotech funding rounds in S...

15 biotech companies in China you should know about

Check out 10 of the top biotech companies in China, as the country has seen its biotech sector grow in the last decade. The post 15 biotech companies in China you should know about...

Top biotech deals in September 2026

September is often a strong month for the biopharma sector as the industry returns from the summer lull, keen on forging biotech deals. The post Top biotech deals in September 2026...

<![CDATA[A Leadership Call to Action for Biotech]]>

Optogenics researchers win a Nobel Prize; Roche bets on Alector brain drug

The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and CSL cut licensing deals and the FDA endorsed broader us...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

<![CDATA[A Steadying Trajectory: Biopharma Review and Outlook]]>

<![CDATA[Build the Launch, Then Cut the Deal: A Smarter Playbook for Emerging Biotech Value]]>

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

Biogen: The Bull Case Is Extending Beyond Alzheimer's (Rating Upgrade)

Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

They could both outperform the market over the medium term, but one appears to have a clear edge.

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

<![CDATA[Moonwalk Biosciences Closes $70 Million Series B ]]>

<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>

XBI: Big Pharma Can Keep The 76% Rally Going